The European market provides what can be a bewildering number of different opportunities. The countries that make up the European market are very different and within each country there may be regional variations and distinct market segments. Working out where best to launch and commercialise a medical product can be a difficult decision. Multiple factors will influence the decision but one factor that may be of major importance is the likelihood that the reimbursement system in your markets of interest will allow you a sufficient volume of sales at an attractive price.
Translucency offers RAMP™ covering one or more of the major EU markets. RAMP™ reports identify the relevant reimbursement environment, how a particular product maps against existing reimbursement categories, data requirements to achieve reimbursement, likely price constraints and expected timescale. RAMP™ gives you the key information you need to plan for the successful commercialisation of a healthcare product or service in Europe.